Vertex Pharmaceuticals (VRTX) Net Margin (2009 - 2026)
Vertex Pharmaceuticals (VRTX) reported Net Margin of 32.99% for Q2 2026, down 1.85 percentage points from 34.84% a year earlier and down 1.54 percentage points from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Net Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vertex Pharmaceuticals' Net Margin came in at 35.00%, up 3.14 percentage points year-over-year; for FY2025, it came in at 32.94%, up 37.80 percentage points from FY2024.
- Net Margin has a five-year change of -10.76 percentage points (FY2020 to FY2025).
- By year, Net Margin came in at -4.86% in FY2024 (-41.54 pp), 36.68% in FY2023 (-0.52 pp), 37.20% in FY2022 (+6.28 pp) and 30.92% in FY2021 (-12.78 pp).
- The Q2 2026 figure ranks as the lowest quarterly Net Margin since Q1 2025.
- Year over year, Net Margin gained in three of the last eight quarters, with an average year-over-year change of +19.36 percentage points.
- The high point for year-over-year Net Margin in five years was Q2 2025 (a gain of 170.67 percentage points); the low point was Q2 2024 (a drop of 172.56 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 34.53% (Q1 2026), 37.34% (Q4 2025) and 35.20% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.09 Bn | 1,194.71 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 656.38 Bn | 576.24 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 510.79 Bn | 478.80 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 363.00 Bn | 317.38 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 313.89 Bn | 287.12 Bn | - | - |
| 6 | Astrazeneca | 290.02 Bn | 263.91 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 249.59 Bn | 204.98 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 208.15 Bn | 183.26 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 170.74 Bn | 118.10 Bn | 12.56 Bn | 19.55% |
| 10 | Vertex Pharmaceuticals | 137.20 Bn | 109.19 Bn | 2.91 Bn | 19.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 19.00% |
| Jun 30, 2026 | 32.99% |
| Mar 31, 2026 | 34.53% |
| Dec 31, 2025 | 37.34% |
| Sep 30, 2025 | 35.20% |
| Jun 30, 2025 | 34.84% |
| Mar 31, 2025 | 23.33% |
| Dec 31, 2024 | 31.35% |
| Sep 30, 2024 | 37.71% |
| Jun 30, 2024 | -135.83% |
| Mar 31, 2024 | 40.87% |
| Dec 31, 2023 | 38.48% |
| Sep 30, 2023 | 41.69% |
| Jun 30, 2023 | 36.73% |
| Mar 31, 2023 | 29.47% |
| Dec 31, 2022 | 35.56% |
| Sep 30, 2022 | 39.86% |
| Jun 30, 2022 | 36.90% |
| Mar 31, 2022 | 36.33% |
| Dec 31, 2021 | 37.16% |
API Access
Vertex Pharmaceuticals Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();